Evidence map›Paper›PMID 17021114›Full record

ArticleJournal of clinical microbiology2006

Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping.

Ted E Schutzbank, Susan E Sefers, Nicole Kahmann, Haijing Li, Yi-Wei Tang

Abstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ted E SchutzbankCompuNet Clinical Laboratories, 2308 Sandridge Rd., Dayton, OH 45439, USA. ted.e.schutzbank@questdiagnostics.com
Susan E Sefers
Nicole Kahmann
Haijing Li
Yi-Wei Tang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compared the performances of three hepatitis C virus genotyping methodologies supplied by Bayer, Abbott, and Third Wave Technologies. Genotypes were determined for 136 of 137 specimens by the Bayer method, 121 of 137 specimens by the Invader assay, and only 77 of 137 specimens by the Abbott assay. All reported genotypes were concordant by all three methods.

Indexed as

Molecular Probe TechniquesGenotypeHepacivirusNucleic Acid Amplification TechniquesReagent Kits, DiagnosticSensitivity and SpecificityReagent Kits, Diagnostic

Identifiers

PMID17021114
PMCPMC1594808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.